This week, the U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid, to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. “The FDA recognizes the important role pharmacists have played and continue to play in combatting this pandemic,”...
Read More